| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |